News

IIBB researchers characterize the role of intracellular cholesterol in patients with Alzheimer's disease and Down syndrome

IIBB researchers characterize for the first time the role of intracellular cholesterol in patients with Alzheimer's disease (AD) and Down syndrome (SD).

Read More

The IIBB wishes you Merry Christmas!

Read More

Setmana de la ciència 2019. Jornada de Portes Obertes de l’Institut d'Investigacions Biomèdiques de Barcelona

Read More

The research group "Mitochondrial Regulation of Cell Death", from the IIBB, has obtained a Project for the Cancer Call of the Marató TV3

Read More

The Biomedical Research Institute of Barcelona (IIBB) leads the research network "Metabolic Diseases and Cancer", recently created for the identification of therapeutic targets.

The network approved by the Ministry of Science, Innovation and Universities, will be coordinated by Professor Jose Carlos Fernández-Checa and has the participation of four research groups linked t

Read More

A study demonstrates how mitochondrial oxidative stress regulates amyloid beta (Aβ) clearance by oxidative inactivation of the principal Aβ-degrading enzymes

Recent evidence indicates that decreased clearance of amyloid beta (Aβ) is the driving force leading to its toxic accumulation in late-onset (sporadic) Alzheimer’s disease.  Levels and activity of

Read More

A study by Dr. Vicenta Llorente-Cortés describes a biomarker that predicts the risk of developing cardiovascular diseases in advance.

The work, published in Atherosclerosis, shows that the levels of the sLRP1 protein in blood can indicate the risk of cardiovascular disease in people who do not present any symptoms.

Read More

Pages